Literature DB >> 10329251

A quantitative analysis of vascularization and perfusion of human glioma xenografts at different implantation sites.

H J Bernsen1, P F Rijken, N E Hagemeier, A J van der Kogel.   

Abstract

The effect of tissue site of implantation of four different human gliomas on tumor vascularity and perfusion was examined. Vascular parameters of gliomas implanted subcutaneously in the nude mouse and intracerebrally in the nude rat were analyzed. Tumor vessels were stained with an antibody to collagen type IV and perfusion was investigated with the perfusion marker Hoechst 33342. Characteristic vascular patterns were observed in both intracerebral and subcutaneous xenografts belonging to the same tumor line. Major differences in vascular architecture and in the degree of vascularization were noted in comparisons of the two implantation sites for the same tumor line. Tumor perfusion was highly variable for both locations of tumor growth. Distinct differences between the implantation sites of similar tumor lines in vascular perfusion, intervascular distance, and vascular density were present. Incomplete perfusion of vascular structures, as seen in this study, may result in reduced delivery of oxygen to tumor areas. Therefore, measurements of vascular density and intervascular distance alone, without knowledge of the perfusion status, may not be sufficient to estimate the degree of tumor oxygenation. Furthermore, differences in vascular parameters may have important consequences for treatment modalities such as radiotherapy and chemotherapy. Thus, the findings in our study suggest that care has to be taken in extrapolating therapy results obtained with subcutaneous glioma tumor models to the original growth location of gliomas, the brain, due to major differences in vasculature. Copyright 1999 Academic Press.

Entities:  

Mesh:

Year:  1999        PMID: 10329251     DOI: 10.1006/mvre.1999.2143

Source DB:  PubMed          Journal:  Microvasc Res        ISSN: 0026-2862            Impact factor:   3.514


  9 in total

1.  How stereological analysis of vascular morphology can quantify the blood volume fraction as a marker for tumor vasculature: comparison with magnetic resonance imaging.

Authors:  Adriana T Perles-Barbacaru; Boudewijn P J van der Sanden; Regine Farion; Hana Lahrech
Journal:  J Cereb Blood Flow Metab       Date:  2011-11-09       Impact factor: 6.200

2.  Preclinical Efficacy of the MDM2 Inhibitor RG7112 in MDM2-Amplified and TP53 Wild-type Glioblastomas.

Authors:  Maite Verreault; Charlotte Schmitt; Lauriane Goldwirt; Kristine Pelton; Samer Haidar; Camille Levasseur; Jeremy Guehennec; David Knoff; Marianne Labussière; Yannick Marie; Azra H Ligon; Karima Mokhtari; Khê Hoang-Xuan; Marc Sanson; Brian M Alexander; Patrick Y Wen; Jean-Yves Delattre; Keith L Ligon; Ahmed Idbaih
Journal:  Clin Cancer Res       Date:  2015-10-19       Impact factor: 12.531

3.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

Review 4.  Antiangiogenic therapy in brain tumor models.

Authors:  H J Bernsen; A J van der Kogel
Journal:  J Neurooncol       Date:  1999       Impact factor: 4.130

5.  Influence of hepatic arterial blockage on blood perfusion and VEGF, MMP-1 expression of implanted liver cancer in rats.

Authors:  Wei-Jian Guo; Jie Li; Wan-Long Ling; Yong-Rui Bai; Wen-Zhu Zhang; Yu-Fan Cheng; Wen-Hua Gu; Jun-Yan Zhuang
Journal:  World J Gastroenterol       Date:  2002-06       Impact factor: 5.742

6.  Vascular normalization in orthotopic glioblastoma following intravenous treatment with lipid-based nanoparticulate formulations of irinotecan (Irinophore C™), doxorubicin (Caelyx®) or vincristine.

Authors:  Maite Verreault; Dita Strutt; Dana Masin; Malathi Anantha; Andrew Yung; Piotr Kozlowski; Dawn Waterhouse; Marcel B Bally; Donald T Yapp
Journal:  BMC Cancer       Date:  2011-04-08       Impact factor: 4.430

7.  Uptake of IgG in osteosarcoma correlates inversely with interstitial fluid pressure, but not with interstitial constituents.

Authors:  C de Lange Davies; B Ø Engesaeter; I Haug; I W Ormberg; J Halgunset; C Brekken
Journal:  Br J Cancer       Date:  2001-12-14       Impact factor: 7.640

8.  Transcriptional factor specificity protein 1 (SP1) promotes the proliferation of glioma cells by up-regulating midkine (MDK).

Authors:  Jingyan Luo; Xiaoxiao Wang; Zhibo Xia; Lixuan Yang; Zhiming Ding; Shiyuan Chen; Bingquan Lai; Nu Zhang
Journal:  Mol Biol Cell       Date:  2014-11-26       Impact factor: 4.138

9.  Effect of antivascular endothelial growth factor treatment on the intratumoral uptake of CPT-11.

Authors:  H Wildiers; G Guetens; G De Boeck; E Verbeken; B Landuyt; W Landuyt; E A de Bruijn; A T van Oosterom
Journal:  Br J Cancer       Date:  2003-06-16       Impact factor: 7.640

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.